Citation of paper, Health utility of patients with advanced gastrointestinal stromal tumors (GIST) after failure of imatinib and sunitinib: findings from GRID, a randomized, double-blind, placebo-controlled phase III study of regorafenib versus placebo

Authors Citing This Paper

AuthorCiting PapersAuthor's PapersAuthor's CitationsAuthor's IF
Robin L Jones135311,4685.5
Joanne Ngeow11423,7314.4
Nielka P Van Erp11062,1953.1
Piotr Rutkowski127832,14317.4
Pawel P Teterycz1333102.6
Nicola Fazio12155,7244.3
Brett A Schroeder16342